386867008: Carteolol hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with adrenergic receptor antagonist mechanism of action (substance)\Substance with beta adrenergic receptor antagonist mechanism of action (substance)\Carteolol hydrochloride (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Substance with beta adrenergic receptor antagonist mechanism of action (substance)\Carteolol hydrochloride (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Hypotensive agent (substance)\Substance with beta adrenergic receptor antagonist mechanism of action (substance)\Carteolol hydrochloride (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Amino alcohol\Alkanolamine (substance)\Propanolamine (substance)\Carteolol hydrochloride (substance)

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Amino alcohol\Alkanolamine (substance)\Propanolamine (substance)\Carteolol hydrochloride (substance)
\Organic compound\Substance with alcohol structure (substance)\Amino alcohol\Alkanolamine (substance)\Propanolamine (substance)\Carteolol hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carteolol hydrochloride (substance)	Is a	Carteolol (substance)	false	Inferred relationship	Some
Carteolol hydrochloride (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Beta adrenergic receptor antagonist (disposition)	true	Inferred relationship	Some
Carteolol hydrochloride (substance)	Is a	Propanolamine (substance)	true	Inferred relationship	Some
Carteolol hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Carteolol (substance)	true	Inferred relationship	Some
Carteolol hydrochloride (substance)	Is a	Non-selective beta-blocking agent	false	Inferred relationship	Some
Carteolol hydrochloride (substance)	Is a	Substance with beta adrenergic receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Carteolol hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carteolol hydrochloride (substance)	Inferred relationship	Some
Carteolol hydrochloride 20 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carteolol hydrochloride (substance)	Inferred relationship	Some
Carteolol hydrochloride 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carteolol hydrochloride (substance)	Inferred relationship	Some
Carteolol hydrochloride 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carteolol hydrochloride (substance)	Inferred relationship	Some
Carteolol hydrochloride 1% opthalmic solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carteolol hydrochloride (substance)	Inferred relationship	Some
Ophthalmic carteolol hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carteolol hydrochloride (substance)	Inferred relationship	Some
Product containing precisely carteolol hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carteolol hydrochloride (substance)	Inferred relationship	Some
Carteolol hydrochloride 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carteolol hydrochloride (substance)	Inferred relationship	Some	1
Carteolol hydrochloride 2.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carteolol hydrochloride (substance)	Inferred relationship	Some	1
Carteolol hydrochloride 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carteolol hydrochloride (substance)	Inferred relationship	Some	1
Carteolol hydrochloride 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carteolol hydrochloride (substance)	Inferred relationship	Some	1
Carteolol hydrochloride 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carteolol hydrochloride (substance)	Inferred relationship	Some	1
Carteolol hydrochloride 2.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carteolol hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely carteolol hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carteolol hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely carteolol hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carteolol hydrochloride (substance)	Inferred relationship	Some	1
Carteolol hydrochloride 20 mg/mL eye drops	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carteolol hydrochloride (substance)	Inferred relationship	Some	1
Carteolol hydrochloride 20 mg/mL eye drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carteolol hydrochloride (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461045011	Carteolol hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1480981014	Carteolol hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
375271000195117	carteololo cloridrato	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
46911000188118	cartéolol chlorhydrate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
798081000172115	chlorhydrate de cartéolol	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module